suma/hemorrhage

REFERENCE TO A "SEQUENCE LISTING" Not Applicable BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention concerns a new isolated and purified strain of virulent, hemorrhagic feline calicivirus, vaccines produced therefrom and the use of the vaccines to protect cats from

TECHNICAL FIELD This invention relates generally to the field of blood loss, and more specifically to new and useful systems and methods for tracking patient blood loss and/or managing patient fluid status. SUMMARY Systems for monitoring blood loss include a display for simultaneously depicting a

INCORPORATION-BY-REFERENCE OF SEQUENCE LISTING The contents of the text file named "ARC612USsubseqlist.txt," which was created on Jan. 3, 2011 and is 149 KB in size, are hereby incorporated by reference in their entirety. FIELD OF THE INVENTION The invention relates generally to the field of nucleic

FIELD OF THE INVENTION The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to tissue factor pathway inhibitor (TFPI), which are useful as therapeutics in and diagnostics of bleeding disorders and/or other pathologies, diseases or disorders in

FIELD OF THE INVENTION The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to tissue factor pathway inhibitor (TFPI), which are useful as therapeutics in and diagnostics of bleeding disorders and/or other pathologies, diseases or disorders in

FIELD OF INVENTION The invention is related to methods of protecting, preventing and reducing intestinal injury in a human subject at risk for or suffering from shock, hemorrhagic shock (HS) or hemorrhagic shock and resuscitation (HS/R) comprising administering heparin binding epidermal growth

FIELD OF INVENTION The invention is related to methods of protecting, preventing and reducing intestinal injury in a human subject at risk for or suffering from shock, hemorrhagic shock (HS) or hemorrhagic shock and resuscitation (HS/R) comprising administering heparin binding epidermal growth

FIELD OF THE INVENTION The present invention relates to a DNA sequence which comprises a nucleotide sequence encoding the Hemorrhagic Enteritis Virus, to proteins encoded thereby, to vectors and DNA constructs comprising the said DNA sequence or essential fragments thereof, and to various uses of

A. BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for the prophylaxis or therapy of intraventricular hemorrhage and hydrocephalus in preterm infants, comprising mesenchymal stem cells. 2. Description of the Related Art According to the WHO,

The present invention concerns a new agent for care of the teeth and the mouth maintaining the gums in a healthy condition, inhibiting the formation of dental plaque and thus particularly eliminating the causes of gingival diseases. Tooth and mouth care agents with such purposes have been known and

FIELD OF THE INVENTION This invention relates to dental flosses and picks. BACKGROUND Dental flosses and picks have long been used to clean the teeth and the gum margin. In the past, certain medicinal ingredients have been incorporated within the picks and floss e.g., fluoride to protect the tooth

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. REFERENCE TO A MICROFICHE APPENDIX Not applicable. FIELD OF THE INVENTION The present invention relates to syndiotactic polypropylene blends having a high degree of flexibility and good optical clarity. More

BACKGROUND OF THE INVENTION The present invention relates to vascular prostheses, and more particularly relates to vascular grafts impregnated with a heparin-containing collagen sealant. Vascular prostheses, commonly referred to as grafts, are typically used as soft tissue prostheses to replace

BACKGROUND OF THE INVENTION The present invention relates to vascular prostheses, and more particularly relates to vascular grafts impregnated with a heparin-containing collagen sealant. Vascular prostheses, commonly referred to as grafts, are typically used as soft tissue prostheses to replace

PRIORITY TO RELATED APPLICATIONS(S) This application claims the benefit of European Patent Application No. 08150173.6, filed Jan. 11, 2008, which is hereby incorporated by reference in its entirety. BACKGROUND OF THE INVENTION Alzheimer's disease (AD) is the most common cause of dementia in later